紫阁徐爽的“逆行人生”

Core Viewpoint - The investment landscape is evolving, with a focus on the pharmaceutical sector and the potential of innovative drug companies, despite recent market fluctuations [3][4][11]. Group 1: Pharmaceutical Sector Insights - The pharmaceutical industry is viewed as having a future, particularly for companies with substantial value propositions, despite recent declines [5][6][11]. - The market has not fully recognized the long-term value of innovative drug companies, indicating potential investment opportunities [4][11]. - The ASCO conference highlighted the increasing presence of Chinese companies in the pharmaceutical sector, suggesting a positive trend for innovative drug development [11]. Group 2: Investment Strategy and Philosophy - The investment strategy emphasizes safety, flexibility, and certainty, with a focus on deep research to identify undervalued opportunities [4][6][10]. - The approach involves a shift from cyclical industries to growth sectors, with a commitment to thorough analysis and long-term tracking of investments [5][9]. - The investment team prioritizes sectors with strong fundamentals and avoids speculative themes, focusing on companies with sustainable business models [9][10]. Group 3: Technology and AI Sector - The AI sector is seen as a developing area, with ongoing penetration and potential for future investment opportunities, though many companies are still in exploratory phases [12]. - The importance of aligning stock selection with positive fundamental changes is emphasized, indicating a cautious approach to AI investments [12]. Group 4: Other Notable Sectors - The refrigerant industry is highlighted as a sector of interest due to regulatory changes and market dynamics that could lead to improved performance for related companies [12].